Market Cap: $4.78M
GL
Galmed Pharmaceuticals Ltd.
GLMD
NASDAQUSD
Market Cap: $4.78M
Analysts estimated GLMD earnings of $-3.18 per share this quarter (Q2). GLMD's actual earnings were $2.86 per share.
GLMD EPS surprise of 189.87%Analysts estimated GLMD earnings of $-3.10 per share this quarter (Q1). GLMD's actual earnings were $2.32 per share.
GLMD EPS surprise of 174.82%Analysts estimated GLMD earnings of $-0.52 per share this quarter (Q4). GLMD's actual earnings were $-0.80 per share.
GLMD EPS surprise of -53.79%Analysts estimated GLMD earnings of $-0.55 per share this quarter (Q3). GLMD's actual earnings were $-0.33 per share.
GLMD EPS surprise of 40.09%Analysts estimated GLMD earnings of $-0.85 per share this quarter (Q2). GLMD's actual earnings were $-0.63 per share.
GLMD EPS surprise of 25.58%Analysts estimated GLMD earnings of $-0.91 per share this quarter (Q1). GLMD's actual earnings were $-0.62 per share.
GLMD EPS surprise of 31.70%Analysts estimated GLMD earnings of $-3.92 per share this quarter (Q4). GLMD's actual earnings were $-11.76 per share.
GLMD EPS surprise of -200.25%Analysts estimated GLMD earnings of $-0.28 per share this quarter (Q3). GLMD's actual earnings were $-0.24 per share.
GLMD EPS surprise of -12.85%